Wealth Alliance Has $368,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Wealth Alliance lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.4% in the fourth quarter, HoldingsChannel.com reports. The firm owned 4,083 shares of the exchange traded fund’s stock after acquiring an additional 173 shares during the period. Wealth Alliance’s holdings in SPDR S&P Biotech ETF were worth $368,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of XBI. Creative Planning raised its stake in shares of SPDR S&P Biotech ETF by 15.6% in the third quarter. Creative Planning now owns 29,114 shares of the exchange traded fund’s stock valued at $2,876,000 after purchasing an additional 3,920 shares in the last quarter. Howard Capital Management Group LLC raised its stake in SPDR S&P Biotech ETF by 2.6% during the third quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock worth $24,514,000 after acquiring an additional 6,188 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in SPDR S&P Biotech ETF by 74.7% during the third quarter. Sequoia Financial Advisors LLC now owns 4,002 shares of the exchange traded fund’s stock worth $395,000 after acquiring an additional 1,711 shares in the last quarter. Grimes & Company Inc. acquired a new position in SPDR S&P Biotech ETF during the third quarter worth $207,000. Finally, Mount Yale Investment Advisors LLC raised its stake in SPDR S&P Biotech ETF by 12.5% during the third quarter. Mount Yale Investment Advisors LLC now owns 2,842 shares of the exchange traded fund’s stock worth $281,000 after acquiring an additional 315 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $91.70 on Friday. The stock has a fifty day moving average price of $91.36 and a two-hundred day moving average price of $95.97. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The firm has a market capitalization of $6.99 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.